Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hualan Wu"'
Autor:
Qing Zhang, Yuying Qi, Shuanghu Wang, Fangling Zhao, Lili Zou, Quan Zhou, Peiwu Geng, Yun Hong, Hang Yang, Qingfeng Luo, Jianping Cai, Hualan Wu, Dongxu Wang, Hao Chen, Jiefu Yang, Dapeng Dai
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Cytochrome P450 2C9 (CYP2C9) participates in about 15% of clinical drug metabolism, and its polymorphism is associated with individual drug metabolism differences, which may lead to the adverse drug reactions (ADRs). In this study, 1163 Chinese Han i
Externí odkaz:
https://doaj.org/article/2bae00f930ae474fafd9d8c35a4a0063
Autor:
Dongxu Wang, Hualan Wu, Min Dong, Qing Zhang, Anxu Zhao, Xinlong Zhao, Jia Chong, Minghui Du, Yan Wang, Haifeng Shi, Shuanghu Wang, Fang Wang, Jianping Cai, Jiefu Yang, Dapeng Dai, Hao Chen
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundsGene polymorphisms are critical for variations in warfarin dose. To date, more than 70 CYP2C9 alleles have been identified. This study was designed to clarify the clinical significance of CYP2C9*non-3 variants to warfarin sensitivity in Ch
Externí odkaz:
https://doaj.org/article/be7370e51a18484e80b7f75c39585d2a
Autor:
Jia Chong, Hao Chen, Dapeng Dai, Shuanghu Wang, Quan Zhou, Junpeng Liu, You Lü, Hualan Wu, Minghui Du, Feifei Chen, Hui Jiang, Yunfang Zhou, Jiefu Yang
Publikováno v:
Pharmaceutical Biology, Vol 58, Iss 1, Pp 630-635 (2020)
Context Rivaroxaban and ticagrelor are two common drugs for the treatment of atrial fibrillation and acute coronary syndrome. However, the drug–drug interaction between them is still unknown. Objective To investigate the effects of ticagrelor on th
Externí odkaz:
https://doaj.org/article/6e8c3613c83c425c847cb050c63cc770
Autor:
Qing Xu, Gui Chen, Guimei Chen, Hualan Wu, Yuanyuan Yang, Ziyi Mai, Rui Sun, Ping Luan, Chaowan Guo, Meng Yu, Zhenwei Peng, Zhiqiang Yu
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 347
Nonspecific biodistribution and poor permeability of conventional therapeutic agents in solid tumors severely compromised the antitumor efficacy. Herein, we report a cascade tumor therapeutic nanoplatform consisting of docosahexaenoic acid (DHA) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16babd1711c648887f91a3cac9c128ff
https://pubmed.ncbi.nlm.nih.gov/35569586
https://pubmed.ncbi.nlm.nih.gov/35569586
Autor:
Dongxu, Wang, Da-Peng, Dai, Hualan, Wu, Jia, Chong, You, Lü, Ruoyun, Yin, Xinlong, Zhao, Anxu, Zhao, Jiefu, Yang, Hao, Chen
Publikováno v:
Pharmacogenomics. 21(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e6fa62f2ba50072364929da400c1a27
https://pubmed.ncbi.nlm.nih.gov/32893731
https://pubmed.ncbi.nlm.nih.gov/32893731
Autor:
Wenfeng Feng, Baoping Wang, Hualan Wu, Siyuan Chen, Songtao Qi, Bingbing Ke, Mingzhou Li, Gang Wang, Lijing Ji, Yingjia Li, Guozhong Zhang, Xi-an Zhang, Shichao Zhang, Yunyu Wen, Junjie Liu
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 29(9)
Purpose To date, digital subtraction angiography (DSA) has been considered as the gold imaging modality for assessing graft patency after extracranial–intracranial bypass. The utility of a noninvasive and quantitative method of assessing graft flow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99dd0480c059de72da9ab20e838cd72f
https://pubmed.ncbi.nlm.nih.gov/32807419
https://pubmed.ncbi.nlm.nih.gov/32807419